Onderzoeker
Hendrik Everaert
- Trefwoorden:Geneeskunde
- Disciplines:Landbouwwetenschappen, diergeneeskunde en levensmiddelenwetenschappen
Affiliaties
- Medische Beeldvorming (Onderzoeksgroep)
Lid
Vanaf1 jan 2011 → Heden - nucleaire geneeskunde (Departement)
Lid
Vanaf1 jan 2008 → Heden - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2024 → Heden - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf8 apr 2019 → 28 feb 2023 - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 20 okt 2022 - Medische Beeldvorming en Fysische Wetenschappen (Departement)
Lid
Vanaf1 mrt 2010 → 31 dec 2013 - Medische Beeldvorming en Fysische Wetenschappen (Departement)
Lid
Vanaf1 okt 2002 → 30 sep 2010
Publicaties
11 - 20 van 60
- A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab(2021)
Auteurs: G Awada, Yanina Jansen, Julia Katharina Schwarze, Jens Tijtgat, Lennert Hellinckx, Odrade Gondry, Sim Vermeulen, Sarah Warren, Kelly A Schats, Pieter-Jan van Dam, et al.
Pagina's: 1-18 - Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)(2020)
Auteurs: Gil Awada, Laila Ben Salama, Jennifer De Cremer, Julia Katharina Schwarze, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, A Vanbinst, Alex Michotte, Hendrik Everaert, et al.
Pagina's: 1-12 - An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma(2020)
Auteurs: Stijn De Keukeleire, Julia Katharina Schwarze, G Awada, Hendrik Everaert, A Vanbinst, Louise Cras, Bart Neyns, Sandrine Aspeslagh
Pagina's: 524-527 - Antitumor Activity of Cabozantinib in Metastatic Adult Ewing Sarcoma(2020)
Auteurs: Denis Schallier, Pierre Lesfevre, Hendrik Everaert
Pagina's: 2265-2269 - Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages(2019)
Auteurs: Catarina Xavier, Anneleen Blykers, Damya Laoui, Evangelia Bolli, Ilse Vaneycken, Jessica Bridoux, Henri Baudhuin, G Raes, Hendrik Everaert, Kiavash Movahedi, et al.
Pagina's: 898-906 - Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy(2019)
Auteurs: Teofila Seremet, Yanina Jansen, Simon Planken, Hassan Njimi, Melanie Delaunoy, Hakim El Housni, Gil Awada, Julia Katharina Schwarze, Marleen Keyaerts, Hendrik Everaert, et al.
- Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition(2018)
Auteurs: G Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns
Pagina's: 2156-2158 - The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients(2018)
Auteurs: O C Guler, Benedikt Engels, C Onal, Hendrik Everaert, Robbe Van den Begin, Thierry Gevaert, Mark De Ridder
Pagina's: 484-490 - Population Pharmacokinetic Approach Applied to Positron Emission Tomography(2017)
Auteurs: Peggy Gandia, Cyril Jaudet, Hendrik Everaert, Johannes Heemskerk, A Vanbinst, Johan de Mey, Johnny Duerinck, Bart Neyns, Mark De Ridder, Etienne Chatelut, et al.
Pagina's: 953-961 - Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer(2017)
Auteurs: Vincent Vinh - Hung, Hendrik Everaert, Karim Farid, Navid Djassemi, Jacqueline Baudin-Veronique, Stefanos Bougas, Yuriy Michailovich, Clarisse Joachim-Contaret, Elsa Cécilia-Joseph, Claire Verschraegen, et al.
Pagina's: 312-320